CombinatoRx
CombinatoRx, founded in 2002, was a publicly-traded biopharmaceutical company pioneering the field of synergistic combination pharmaceuticals. The company鈥檚 approach centered on creating product candidates with novel mechanisms of action striking at the biological complexities of human disease. CombinatoRx merged with Neuromed in 2009.